+$15.4M
Net Activity
Institutions Holding
105
Popularity Rank
#4343
Avg Weight
0.08%
Total Value
$123.7M
105 institutions currently hold CRBP, with 53 net buyers and 36 net sellers this quarter.
Institutional Moves (Q1 2026)
Majority Increased
Based on recent trading activity
Net Selling Institutions
36
Net Buying Institutions
53
Top 5 by Value
+$57.1M
Total Buy Value
$36.1M
Total Sell Value
53
Net Buyers
36
Net Sellers
No Form 144 planned sale filings in the last 90 days
No Schedule 13D/13G filings for this ticker
1
Filings (14d)
Corbus Pharmaceuticals entered into a two-year employment agreement with Dr. Leonardo Viana Nicacio as Chief Medical Officer, effective August 3, 2026. The deal includes a $545,000 base salary, a target bonus of up to 40% of salary, and $2.1 million in equity inducement awards split between stock options and restricted stock units. The agreement also outlines severance terms, non-compete, and non-solicitation clauses.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter